Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hypersensitivity Reaction

Free Subscription 03.11.2025 2 Acta Derm Venereol 2 Allergy 12 Allergy Asthma Proc 1 Am J Respir Crit Care Med 2 Ann Allergy Asthma Immunol 1 BMC Pediatr 1 Br J Dermatol 2 Contact Dermatitis 1 Int Arch Allergy Immunol 4 J Allergy Clin Immunol 2 J Am Acad Dermatol 19 J Asthma 1 J Dermatol 1 J Pediatr 1 Pediatr Rev 2 Pediatrics 1 PLoS One 12 Respir Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Derm Venereol

1. 
   Abstracts from 15th Georg Rajka International Symposium on Atopic Dermatitis.
   Acta Derm Venereol. 2025;105:adv44874.
   PubMed         Abstract available
   
   
2. MATHIEU C, Maccari F, Perrot JL, Reguiai Z, et al
   Clinical Impact of Systemic Treatment Choices Made in Current Practice in Elderly Patients with Atopic Dermatitis.
   Acta Derm Venereol. 2025;105:adv44174.
   PubMed         Abstract available
   
   

   
   Allergy

3. FERNANDEZ-BRAVO S, Fernandez-Santamaria R
   Role of Inflammasome in IgE-Mediated Anaphylaxis.
   Allergy. 2025 Oct 25. doi: 10.1111/all.70123.
   PubMed        
   
   
4. ALBERS GJ, Ogger PP, Michalaki C, Stolting H, et al
   Protective Role for Itaconate During Inhaled Allergen Challenge.
   Allergy. 2025 Oct 24. doi: 10.1111/all.70107.
   PubMed         Abstract available
   
   

   
   Allergy Asthma Proc

5. ORAK AKBAY N, Ozdel Ozturk B, Doganci A, Celebi Sozener Z, et al
   The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.
   Allergy Asthma Proc. 2025;46:489-497.
   PubMed         Abstract available
   
   
6. BERNSTEIN DI
   Aeroallergen immunotherapy update: Developments since the third Practice Parameter.
   Allergy Asthma Proc. 2025;46:450-454.
   PubMed         Abstract available
   
   
7. SELNER GE, Nicolaides RE, Chow TG
   Caregiver perceptions of beta-lactam allergy testing for serum sickness-like reactions.
   Allergy Asthma Proc. 2025;46:478-483.
   PubMed         Abstract available
   
   
8. GENIS C, Torun Ozel C, Selmanoglu A, Sengul Emeksiz Z, et al
   Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach.
   Allergy Asthma Proc. 2025;46:e183-e190.
   PubMed         Abstract available
   
   
9. GUPTA RS, Yang MS
   Managing food allergies in each stage of life.
   Allergy Asthma Proc. 2025;46:444-449.
   PubMed         Abstract available
   
   
10. LARENAS-LINNEMANN D, Mosges R
    In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites.
    Allergy Asthma Proc. 2025;46:e176-e182.
    PubMed         Abstract available
    
    
11. FLUGT A, Rasmussen HM, Agertoft L, Moller S, et al
    Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low.
    Allergy Asthma Proc. 2025;46:506-511.
    PubMed         Abstract available
    
    
12. LANG DM
    Management of chronic urticaria: Treatment options when omalizumab fails.
    Allergy Asthma Proc. 2025;46:455-461.
    PubMed         Abstract available
    
    
13. DAVIS J, Ward ER, Huang X, Staggers KA, et al
    Food allergy referral patterns from 2013-2015 to 2016-2018 at Texas Children's Hospital.
    Allergy Asthma Proc. 2025;46:e172-e175.
    PubMed         Abstract available
    
    
14. MILUSKI T, Bhattarai B, Al-Shaikhly T
    Anaphylaxis related to fluoroquinolones: A disproportionality analysis of the FDA Adverse Event Reporting System data base.
    Allergy Asthma Proc. 2025;46:484-488.
    PubMed         Abstract available
    
    
15. YILMAZ D, Yilmaz Topal O, Sengul Emeksiz Z, Dibek Misirlioglu E, et al
    Evaluation of diagnostic tests for suspected hypersensitivity reactions to proton pump inhibitors in children.
    Allergy Asthma Proc. 2025;46:471-477.
    PubMed         Abstract available
    
    
16. WHALLEY D, Balp MM, Naujoks C, Gardner DD, et al
    Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria.
    Allergy Asthma Proc. 2025;46:462-470.
    PubMed         Abstract available
    
    

    
    Am J Respir Crit Care Med

17. TARDIF A, Whitmore GA, Vandemheen KL, Bergeron C, et al
    Patient Factors and Clinical Efficacy of Early Identification and Treatment of COPD and Asthma.
    Am J Respir Crit Care Med. 2025 Oct 7. doi: 10.1164/rccm.202505-1260.
    PubMed         Abstract available
    
    

    
    Ann Allergy Asthma Immunol

18. EROL M, Kim EH, Fisher JA
    Goldilocks Zone: Allergists' Perceptions of Family Anxiety and Investment in Food Allergy Oral Immunotherapy.
    Ann Allergy Asthma Immunol. 2025 Oct 27:S1081-1206(25)01289.
    PubMed         Abstract available
    
    
19. ESTRADA-MENDIZABAL RJ, Moraca P, Castillo-Ivon AJ, Priessnitz J, et al
    Sex-Based Differences in Perioperative Hypersensitivity: A Systematic Review and Meta-Analysis.
    Ann Allergy Asthma Immunol. 2025 Oct 23:S1081-1206(25)01264.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

20. QIU XW, Li LW, Yang H, Wei HX, et al
    Vitamin D is a key indicator influencing the parathyroid hormone level in children 6-18 years with cow's milk protein allergy.
    BMC Pediatr. 2025;25:882.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

21. IVERT LU, Anveden-Berglind I, Gembert K, Eriksson J, et al
    The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study.
    Br J Dermatol. 2025 Oct 24:ljaf418. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Contact Dermatitis

22. LOCKMANN A, Schill T, Schubert S, Buhl T, et al
    Allergic Contact Dermatitis to Trimethylpentanediol/Adipic Acid/Glycerin Crosspolymer in a Lip Balm.
    Contact Dermatitis. 2025 Oct 26. doi: 10.1111/cod.70040.
    PubMed        
    
    
23. ALLICHON S, Litovsky J, Sanchez M, Girard C, et al
    Severe Delayed Hypersensitivity Reaction at Guselkumab Injection Site.
    Contact Dermatitis. 2025 Oct 30. doi: 10.1111/cod.70034.
    PubMed        
    
    

    
    Int Arch Allergy Immunol

24. LI Y, Zong H, Fang M, Luo D, et al
    Comparative effectiveness of approved biologics in treating moderate-to-severe allergic asthma: a systematic review and network meta-analysis.
    Int Arch Allergy Immunol. 2025 Oct 30:1-19. doi: 10.1159/000549116.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

25. MATRICARDI PM
    "Molecular Allergology World Atlas": Calling to bridge IgE microarrays and artificial intelligence.
    J Allergy Clin Immunol. 2025 Oct 28:S0091-6749(25)01039.
    PubMed        
    
    
26. DEN ELZEN CCM, Carvalho A, Bazan-Socha S, Jeurink PV, et al
    HUMAN MILK OLIGOSACCHARIDES AND POLYPHENOLS: MECHANISMS, EFFECTS, AND APPLICATIONS IN ALLERGIES.
    J Allergy Clin Immunol. 2025 Oct 22:S0091-6749(25)01035.
    PubMed         Abstract available
    
    
27. AYDIN E, Azizoglu S, Chong L, Gokhale M, et al
    microRNA-mediated allergic angiogenesis and inflammation evident in a preliminary study of the tears of patients with ocular allergy.
    J Allergy Clin Immunol. 2025 Oct 31:S0091-6749(25)01027.
    PubMed        
    
    
28. KONSTANTINOU GN, Yin Wong LS, Nowak-Wegrzyn A
    Reading the Code of Epitope-specific IgE: Predicting Persistence and Resolution in Peanut Allergy.
    J Allergy Clin Immunol. 2025 Oct 29:S0091-6749(25)01073.
    PubMed        
    
    

    
    J Am Acad Dermatol

29. DULAI AS, Murase EM, Avallone G, Ferrucci SM, et al
    International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes.
    J Am Acad Dermatol. 2025 Oct 29:S0190-9622(25)03123.
    PubMed        
    
    
30. FISHER C, Wohltmann WE
    JAAD Game Changers: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
    J Am Acad Dermatol. 2025 Oct 29:S0190-9622(25)03101.
    PubMed        
    
    

    
    J Asthma

31. WIDGE S, Paquet J, Ling L, Vethanayagam D, et al
    Psychiatric screening tools in asthma and their barriers to clinical utilization: a systematic review.
    J Asthma. 2025 Jul 10:1-16. doi: 10.1080/02770903.2025.2531499.
    PubMed         Abstract available
    
    
32. SHI X, Li Q, Hu Z, Yang L, et al
    Preserved ratio impaired spirometry and mortality in non-smoking asthma: a population-based cohort study.
    J Asthma. 2025 Jul 10:1-14. doi: 10.1080/02770903.2025.2526388.
    PubMed         Abstract available
    
    
33. SENBAYKAL YIGIT E, Taskirdi I, Haci IA, Tuncel T, et al
    Artificial Intelligence Performance in Pediatric Asthma.
    J Asthma. 2025 Jul 11:1-11. doi: 10.1080/02770903.2025.2531500.
    PubMed         Abstract available
    
    
34. GEHLSEN K, Carrasco A, Hooghius J, Pyles S, et al
    Neuromodulation for the treatment of moderate to severe asthma - a pilot first-in-human clinical study.
    J Asthma. 2025 Jul 11:1-9. doi: 10.1080/02770903.2025.2531501.
    PubMed         Abstract available
    
    
35. PENG L, Li M, Xiao L, Lei L, et al
    The impact of m6A methyltransferase METTL3 on airway remodeling in bronchial asthma.
    J Asthma. 2025 Jul 14:1-14. doi: 10.1080/02770903.2025.2531497.
    PubMed         Abstract available
    
    
36. ABDELMAWGOOD IA, Kotb MA, Waleed Ebeed B, Samy Hassan Eltras H, et al
    2-Hydroxychalcone Attenuates Airway Inflammation, Oxidative Stress, and NF-kappaB Activation in Ovalbumin-Induced Asthma Model.
    J Asthma. 2025 Jun 27:1-13. doi: 10.1080/02770903.2025.2526384.
    PubMed         Abstract available
    
    
37. KUPRYS-LIPINSKA I, Debowski T, Palczynski C, Hozejowski R, et al
    Impact of smoking on asthma control with extrafine beclomethasone/formoterol: post hoc analysis of a prospective cohort study.
    J Asthma. 2025 Jun 27:1-12. doi: 10.1080/02770903.2025.2526373.
    PubMed         Abstract available
    
    
38. ISIK E, Schultz RJ, Fredland NM
    Stepping Stones to Adolescent Asthma Self-management: Dealing with Ups and Downs.
    J Asthma. 2025 Jun 27:1-13. doi: 10.1080/02770903.2025.2526375.
    PubMed         Abstract available
    
    
39. WANG H, Wang J, He X
    The efficacy of dexamethasone compared to prednisone/prednisolone for the management of pediatric patients with acute exacerbation of asthma: a systematic review and meta-analysis.
    J Asthma. 2025 Jun 27:1-12. doi: 10.1080/02770903.2025.2526376.
    PubMed         Abstract available
    
    
40. VAZQUEZ-RODRIGUEZ EM, Vazquez-Rodriguez CF, Vazquez-Nava F, de Leon-Escobedo R, et al
    Lifestyle and Environmental Risk Factors for Comorbidities in Adolescents with Asthma.
    J Asthma. 2025 Jun 27:1-12. doi: 10.1080/02770903.2025.2526377.
    PubMed         Abstract available
    
    
41. KATHIRAVETPILLAI N, van Buul AR, Ezinga M, Koehorst-Ter Huurne K, et al
    Inhaled Muscarinic Antagonists during Pregnancy in Women with Asthma: Case Series from a Dutch Prospective Observational Cohort Study.
    J Asthma. 2025 Jul 14:1-10. doi: 10.1080/02770903.2025.2531493.
    PubMed         Abstract available
    
    
42. OZTOSUN B, Baskan AK, Kalayci A, Ozceker D, et al
    Interaction between Secondhand Smoke Exposure and IL-17 Gene Polymorphism in Pediatric Asthma.
    J Asthma. 2025 Jul 29:1-16. doi: 10.1080/02770903.2025.2539802.
    PubMed         Abstract available
    
    
43. ZHANG P, Bao Y, Zhou X, Lu Y, et al
    Comparing the effects of two low-dose budesonide suspension nebulization treatments on asthma among young children: A multicenter study.
    J Asthma. 2025 Jul 30:1-16. doi: 10.1080/02770903.2025.2539810.
    PubMed         Abstract available
    
    
44. GARCIA MORALES OM, Celis-Preciado CA, Solarte I, Velosa-Porras J, et al
    Attitudes, barriers, and facilitators for the use of rescue therapy in patients with mild to moderate asthma.
    J Asthma. 2025 Aug 1:1-10. doi: 10.1080/02770903.2025.2531490.
    PubMed         Abstract available
    
    
45. LI Z, Zhu S
    STOML2 knockdown inhibits inflammation and airway remodeling of PDGF-BB-induced airway smooth-muscle cells by the MAPK pathway.
    J Asthma. 2025;62:1978-1987.
    PubMed         Abstract available
    
    
46. BUENDIA JA, Guerrero Patino D, Buendia Sanchez JA
    Montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: Cost-utility analysis.
    J Asthma. 2025 Aug 13:1-10. doi: 10.1080/02770903.2025.2546348.
    PubMed         Abstract available
    
    
47. TUONG LC, Ramsey A, Patrawala S, Kraude R, et al
    Inpatient Electronic-Consults for Asthma Hospitalization Improve Outpatient Outcomes.
    J Asthma. 2025 Aug 22:1-7. doi: 10.1080/02770903.2025.2548534.
    PubMed         Abstract available
    
    
48. MAHESHWARI A, De S
    Oscillometry-defined small airway dysfunction in steroid-naive adult bronchial asthma: association with eosinophilic and non-eosinophilic phenotypes.
    J Asthma. 2025 Sep 5:1-7. doi: 10.1080/02770903.2025.2552737.
    PubMed         Abstract available
    
    
49. MO S, Wang J, Li X, Xie Y, et al
    Causal Relationship Between Fatty Acid Metabolism and Allergic Asthma: A Mendelian Randomization and Multi-Omics Study.
    J Asthma. 2025 Oct 30:1-19. doi: 10.1080/02770903.2025.2580995.
    PubMed         Abstract available
    
    

    
    J Dermatol

50. HAMAMURA Y, Niimura T, Matsumoto K, Kambara T, et al
    Cotrimoxazole-Induced Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms With Persistent Human Herpesvirus-6 DNA Detection and Flare Without Elevated TARC Levels.
    J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70028.
    PubMed        
    
    

    
    J Pediatr

51. TIANO R, Ruan E, Shah D, Chow TG, et al
    Safety of Direct Amoxicillin Challenges to Evaluate Penicillin Allergy in Infants and Toddlers.
    J Pediatr. 2025 Oct 23:114867. doi: 10.1016/j.jpeds.2025.114867.
    PubMed         Abstract available
    
    

    
    Pediatr Rev

52. KUNTZMAN K, Koumbourlis A, Ogunlesi F
    Breathing Easier: Optimizing Pulmonary Health in Children With Sickle Cell Disease.
    Pediatr Rev. 2025;46:633-639.
    PubMed         Abstract available
    
    

    
    Pediatrics

53. LEW A, House S, Flaherty B, Ritter V, et al
    Trends in Lower Respiratory Tract Diagnoses and Nonrecommended Bronchiolitis Therapies.
    Pediatrics. 2025;156:e2025071946.
    PubMed         Abstract available
    
    
54. PAPPALARDO AA, Youssef C, Hardy P, Hingston D, et al
    Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.
    Pediatrics. 2025;156:e2025071143.
    PubMed         Abstract available
    
    

    
    PLoS One

55. DOS SANTOS AF, Costa R, Pereira H, Pedro AR, et al
    Development and validation of an asthma self-knowledge questionnaire.
    PLoS One. 2025;20:e0333760.
    PubMed         Abstract available
    
    

    
    Respir Med

56. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    PubMed         Abstract available
    
    
57. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    PubMed         Abstract available
    
    
58. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    PubMed         Abstract available
    
    
59. TAHMAZ T, Aslan GK, Yeldan I, Okumus NG, et al
    Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis.
    Respir Med. 2025;248:108380.
    PubMed         Abstract available
    
    
60. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    PubMed         Abstract available
    
    
61. LUO W, Zheng X, Zhang J, Li A, et al
    Component-resolved diagnostics study on nut sensitization and cross-reactivity in China.
    Respir Med. 2025;248:108365.
    PubMed         Abstract available
    
    
62. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    PubMed         Abstract available
    
    
63. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed         Abstract available
    
    
64. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    PubMed         Abstract available
    
    
65. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed         Abstract available
    
    
66. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    PubMed         Abstract available
    
    
67. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.